ArticleInternational journal of pharmaceutics: X2023

End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations.

Laurent Larivière et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.